DRTS

NASDAQ 已收盘

Alpha Tau Medical Ltd.

13.08 USD
+0.13+9.73%
盘后 12.07 +1.26%
2026-08-03
市值
$1.18B
市盈率
EPS
-0.67
股息率
52 周区间
2.98 – 14.11
成交量
582.68K
Beta
1.17
目标价
14.20
52W 低 2.9852W 高 14.11
价格走势

公司简介

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the trea...